Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Yevgeniy Semenov, M.D.

Title
Institution
Department
Address

Overview
Dr. Semenov's research is focused on investigating the epidemiology, economic burden, and societal benefits of medical interventions in the treatment of dermatologic disorders, integrating the patient experience and health-related quality of life into clinical decision making. Additionally, Dr. Semenov's work leverages existing healthcare informatics infrastructure and novel machine learning approaches to develop robust prediction models for treatment selection and disease prognosis in the treatment of metastatic melanoma.

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Tang K, Tiu BC, Wan G, Zhang S, Nguyen N, Leung B, Gusev A, Reynolds KL, Kwatra SG, Semenov YR. Pre-Existing Autoimmune Disease and Mortality in Patients Treated with Anti-PD-1 and Anti-PD-L1 Therapy. J Natl Cancer Inst. 2022 08 08; 114(8):1200-1202. PMID: 35188215; PMCID: PMC9360452.
    Citations:    Fields:    
  2. Theodosakis N, Yoon J, Young K, Getachew E, Mostaghimi A, Semenov Y. Validation of case identification for hyperpigmentation in the setting of medication use using international classification of diseases coding. J Eur Acad Dermatol Venereol. 2022 Jul 05. PMID: 35789040.
    Citations:    Fields:    
  3. Deng J, Parthasarathy V, Adawi W, Bordeaux Z, Sutaria N, Gami A, Taylor M, Lee KK, Marani M, Brown I, Kambala A, Cornman HL, Alajmi A, Pritchard T, Oladipo OO, Semenov YR, Kwatra SG. Risk of Hematologic Cancer in Patients With Undifferentiated Pruritus. JAMA Dermatol. 2022 07 01; 158(7):791-795. PMID: 35612839; PMCID: PMC9134041.
    Citations:    Fields:    Translation:Humans
  4. Said JT, Talia J, Wei E, Mostaghimi A, Semenov Y, Giobbie-Hurder A, Chen ST, LeBoeuf NR. Impact of biologic therapy on cancer outcomes in patients with immune checkpoint inhibitor-induced bullous pemphigoid. J Am Acad Dermatol. 2022 Jun 30. PMID: 35779636.
    Citations:    Fields:    
  5. Asdourian MS, Shah N, Jacoby TV, Semenov YR, Otto T, Thompson LL, Dee EC, Reynolds KL, Chen ST. Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade. J Am Acad Dermatol. 2022 Jun 20. PMID: 35738514.
    Citations:    Fields:    
  6. Asdourian MS, Jacoby TV, Shah N, Thompson LL, Otto T, Semenov YR, LeBoeuf NR, Reynolds KL, Dewan AK, Chen ST. Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A multicenter retrospective study. J Am Acad Dermatol. 2022 Jun 17. PMID: 35724890.
    Citations:    Fields:    
  7. Tiu BC, Zubiri L, Iheke J, Pahalyants V, Theodosakis N, Ugwu-Dike P, Seo J, Tang K, Sise ME, Sullivan R, Naidoo J, Mooradian MJ, Semenov YR, Reynolds KL. Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study. J Immunother Cancer. 2022 06; 10(6). PMID: 35705313; PMCID: PMC9204442.
    Citations:    Fields:    Translation:Humans
  8. Le TK, Brown I, Goldberg R, Taylor MT, Deng J, Parthasarathy V, Bordeaux ZA, Alphonse MP, Kwatra MM, Naranbhai V, Gusev A, Alhariri J, LeBoeuf NR, Reynolds KL, Cappelli LC, Naidoo J, Brahmer JR, Kang S, Semenov YR, Kwatra SG. Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Pharmacovigilance Study. J Invest Dermatol. 2022 May 20. PMID: 35605659.
    Citations:    Fields:    
  9. Sutaria N, Semenov YR, Kwatra SG. Understanding racial disparities in prurigo nodularis. J Am Acad Dermatol. 2022 09; 87(3):e111-e112. PMID: 35577228.
    Citations:    Fields:    
  10. Asdourian MS, Shah N, Jacoby TV, Thompson LL, Otto T, Semenov YR, Reynolds KL, Chen ST. Evaluating patterns of co-occurrence between cutaneous and noncutaneous immune-related adverse events after immune checkpoint inhibitor therapy. J Am Acad Dermatol. 2022 May 13. PMID: 35577231.
    Citations:    Fields:    
  11. Gopinath S, Sutaria N, Bordeaux ZA, Parthasarathy V, Deng J, Taylor MT, Marani M, Lee K, Pritchard T, Alajmi A, Adawi W, Oladipo OO, Semenov YR, Alphonse M, Kwatra SG. Reduced serum pyridoxine and 25-hydroxyvitamin D levels in adults with chronic pruritic dermatoses. Arch Dermatol Res. 2022 May 10. PMID: 35534780.
    Citations:    Fields:    
  12. Said JT, Liu M, Talia J, Singer SB, Semenov YR, Wei EX, Mostaghimi A, Nelson CA, Giobbie-Hurder A, LeBoeuf NR. Risk Factors for the Development of Bullous Pemphigoid in US Patients Receiving Immune Checkpoint Inhibitors. JAMA Dermatol. 2022 05 01; 158(5):552-557. PMID: 35416925; PMCID: PMC9008562.
    Citations:    Fields:    Translation:Humans
  13. Pahalyants V, Murphy WS, Klebanov N, Lu C, Theodosakis N, Klevens MR, Estiri H, Lilly E, Asgari M, Semenov YR. Reply to: "COVID-19 vaccination in IMID patients receiving rituximab: A personalized regimen should be formulated". J Am Acad Dermatol. 2022 07; 87(1):e47-e48. PMID: 35364217; PMCID: PMC8961936.
    Citations:    Fields:    Translation:HumansPHPublic Health
  14. Wongvibulsin S, Parthasarathy V, Pahalyants V, Murphy W, Sutaria N, Roh YS, Bordeaux ZA, Deng J, Taylor MT, Semenov YR, Kwatra SG. Latent class analysis identification of prurigo nodularis comorbidity phenotypes. Br J Dermatol. 2022 05; 186(5):903-905. PMID: 34927720.
    Citations:    Fields:    Translation:Humans
  15. Parthasarathy V, Pollock JR, McNeely GL, Hogan JS, Bordeaux ZA, Trinh P, Deng J, Swanson DL, Sharfstein JM, Semenov YR, Kwatra SG. A cross-sectional analysis of trends in dermatology practice size in the United States from 2012 to 2020. Arch Dermatol Res. 2022 Mar 14. PMID: 35287181.
    Citations:    Fields:    
  16. Sutaria N, Alphonse MP, Roh YS, Choi J, Parthasarathy V, Deng J, Bordeaux ZA, Taylor MT, Pritchard T, Kim N, Aguh C, Semenov YR, Archer NK, Garza LA, Kang S, Kwatra SG. Cutaneous Transcriptomics Identifies Fibroproliferative and Neurovascular Gene Dysregulation in Prurigo Nodularis Compared with Psoriasis and Atopic Dermatitis. J Invest Dermatol. 2022 09; 142(9):2537-2540. PMID: 35257721; PMCID: PMC9391257.
    Citations:    Fields:    
  17. Asdourian MS, Otto TS, Jacoby TV, Shah N, Thompson LL, Blum SM, Reynolds KL, Semenov YR, Lawrence DP, Sullivan RJ, Boland GM, Villani AC, Chen ST. Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma. J Am Acad Dermatol. 2022 Feb 19. PMID: 35192899.
    Citations:    Fields:    
  18. Sutaria N, Marani M, Choi J, Roh YS, Parthasarathy V, Deng J, Bordeaux ZA, Taylor MT, Lee KK, Pritchard T, Alajmi A, Adawi W, Semenov YR, Alphonse MP, Kwatra SG. Racial differences in dysregulation of the renin-angiotensin-aldosterone system in patients with prurigo nodularis. J Dermatol Sci. 2022 Feb; 105(2):130-136. PMID: 35151532.
    Citations:    Fields:    Translation:Humans
  19. Tang K, Seo J, Tiu BC, Le TK, Pahalyants V, Raval NS, Ugwu-Dike PO, Zubiri L, Naranbhai V, Carrington M, Gusev A, Reynolds KL, LeBoeuf NR, Asgari MM, Kwatra SG, Semenov YR. Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy. JAMA Dermatol. 2022 Feb 01; 158(2):189-193. PMID: 35019948; PMCID: PMC8756357.
    Citations: 6     Fields:    Translation:Humans
  20. Theodosakis N, Ugwu-Dike P, Pahalyants V, Reynolds K, Semenov Y. Title: Immune-checkpoint inhibitor therapy is underutilized in the US: A multi-institutional cohort analysis. Immunol Lett. 2022 04; 244:43-44. PMID: 34974035.
    Citations:    Fields:    Translation:Humans
  21. Gil J, Rezeli M, Lutz EG, Kim Y, Sugihara Y, Malm J, Semenov YR, Yu KH, Nguyen N, Wan G, Kemény LV, Kárpáti S, Németh IB, Marko-Varga G. An Observational Study on the Molecular Profiling of Primary Melanomas Reveals a Progression Dependence on Mitochondrial Activation. Cancers (Basel). 2021 Dec 01; 13(23). PMID: 34885173.
    Citations:    
  22. Raval NS, Hodges WT, Ugwu-Dike PO, Godoy F, Ansstas G, Cornelius LA, Musiek AC, Asgari MM, Semenov YR. Racial and socioeconomic differences in acral lentiginous melanoma outcomes: A Surveillance, Epidemiology, and End Results analysis. J Am Acad Dermatol. 2022 Oct; 87(4):866-867. PMID: 34813908.
    Citations:    Fields:    
  23. Gusev A, Groha S, Taraszka K, Semenov YR, Zaitlen N. Constructing germline research cohorts from the discarded reads of clinical tumor sequences. Genome Med. 2021 11 08; 13(1):179. PMID: 34749793; PMCID: PMC8576948.
    Citations: 1     Fields:    Translation:HumansCells
  24. Sutaria N, Alphonse MP, Marani M, Parthasarathy V, Deng J, Wongvibulsin S, Williams K, Roh YS, Choi J, Bordeaux Z, Pritchard T, Dillen C, Semenov YR, Kwatra MM, Archer NK, Garza LA, Dong X, Kang S, Kwatra SG. Cluster Analysis of Circulating Plasma Biomarkers in Prurigo Nodularis Reveals a Distinct Systemic Inflammatory Signature in African Americans. J Invest Dermatol. 2022 05; 142(5):1300-1308.e3. PMID: 34717952; PMCID: PMC9038640.
    Citations:    Fields:    Translation:Humans
  25. Roh YS, Marani M, Choi U, Sutaria N, Parthasarathy V, Deng J, Bordeaux ZA, Taylor MT, Semenov YR, Kwatra SG. Validation of International Classification of Diseases Tenth Revision code for prurigo nodularis. J Am Acad Dermatol. 2022 08; 87(2):482-484. PMID: 34695528.
    Citations:    Fields:    Translation:Humans
  26. Estiri H, Strasser ZH, Brat GA, Semenov YR, Patel CJ, Murphy SN. Evolving phenotypes of non-hospitalized patients that indicate long COVID. BMC Med. 2021 09 27; 19(1):249. PMID: 34565368; PMCID: PMC8474909.
    Citations: 18     Fields:    Translation:Humans
  27. Sutaria N, Adawi W, Brown I, Parthasarathy V, Roh YS, Choi J, Bordeaux ZA, Trinh P, Le TK, Deng J, Semenov YR, Kwatra SG. Racial disparities in mortality among patients with prurigo nodularis: A multi-center cohort study. J Am Acad Dermatol. 2022 02; 86(2):487-490. PMID: 34560195; PMCID: PMC8810612.
    Citations:    Fields:    Translation:Humans
  28. Pahalyants V, Murphy WS, Klebanov N, Lu C, Theodosakis N, Klevens RM, Estir H, Lilly E, Asgari M, Semenov YR. Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts. J Am Acad Dermatol. 2022 01; 86(1):252-255. PMID: 34509536; PMCID: PMC8428982.
    Citations: 2     Fields:    Translation:Humans
  29. Zubiri L, Molina GE, Mooradian MJ, Cohen J, Durbin SM, Petrillo L, Boland GM, Juric D, Dougan M, Thomas MF, Faje AT, Rengarajan M, Guidon AC, Chen ST, Okin D, Medoff BD, Nasrallah M, Kohler MJ, Schoenfeld SR, Karp-Leaf RS, Sise ME, Neilan TG, Zlotoff DA, Farmer JR, Bardia A, Sullivan RJ, Blum SM, Semenov YR, Villani AC, Reynolds KL. Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer. J Immunother Cancer. 2021 09; 9(9). PMID: 34544895; PMCID: PMC8454442.
    Citations: 1     Fields:    Translation:Humans
  30. Zhang J, Erickson S, Semenov YR, Council ML. Surgical Outcomes and Risk Factors for Apical Triangle Basal Cell Carcinomas: A Single Institution Analysis. Dermatol Surg. 2021 08 01; 47(8):1125-1127. PMID: 33867464.
    Citations:    Fields:    Translation:Humans
  31. Estiri H, Strasser ZH, Brat GA, Semenov YR, Patel CJ, Murphy SN. Evolving Phenotypes of non-hospitalized Patients that Indicate Long Covid. medRxiv. 2021 Jul 10. PMID: 33948602; PMCID: PMC8095212.
    Citations:    
  32. Choi J, Sutaria N, Roh YS, Bordeaux Z, Sweren RJ, Semenov YR, Kwatra SG. Racial and ethnic disparities in inpatient health care utilization for mycosis fungoides: A cross-sectional analysis of the 2012-2017 National Inpatient Sample. J Am Acad Dermatol. 2022 06; 86(6):1408-1410. PMID: 34116099.
    Citations:    Fields:    Translation:Humans
  33. Sutaria N, Parthasarathy V, Roh YS, Choi J, Bordeaux ZA, Trinh P, Le TK, Semenov YR, Kwatra SG. Itch in skin of colour: a multicentre cross-sectional study. Br J Dermatol. 2021 09; 185(3):652-654. PMID: 33893648.
    Citations: 1     Fields:    Translation:Humans
  34. Whang KA, Le TK, Khanna R, Williams KA, Roh YS, Sutaria N, Choi J, Gabriel S, Chavda R, Semenov Y, Kwatra SG. Health-related quality of life and economic burden of prurigo nodularis. J Am Acad Dermatol. 2022 03; 86(3):573-580. PMID: 34058278.
    Citations: 3     Fields:    Translation:Humans
  35. Hodges WT, Bhat T, Raval NS, Herbosa C, Ugwu-Dike P, Kwatra SG, Musiek A, Mann C, Semenov YR. Biologics utilization for psoriasis is lower in black compared with white patients. Br J Dermatol. 2021 07; 185(1):207-209. PMID: 33567102.
    Citations: 1     Fields:    Translation:Humans
  36. Klebanov N, Pahalyants V, Murphy WS, Theodosakis N, Zubiri L, Klevens RM, Kwatra SG, Lilly E, Reynolds KL, Semenov YR. Risk of COVID-19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors. Oncologist. 2021 05; 26(5):e898-e901. PMID: 33783099; PMCID: PMC8100539.
    Citations: 6     Fields:    Translation:HumansCells
  37. Wongvibulsin S, Sutaria N, Williams KA, Huang AH, Choi J, Roh YS, Hong M, Kelley D, Pahalyants V, Murphy W, Alphonse MP, Bakhshi P, Walia A, Semenov YR, Kwatra SG. A Nationwide Study of Prurigo Nodularis: Disease Burden and Healthcare Utilization in the United States. J Invest Dermatol. 2021 10; 141(10):2530-2533.e1. PMID: 33823182.
    Citations: 2     Fields:    Translation:Humans
  38. Wongvibulsin S, Pahalyants V, Kalinich M, Murphy W, Yu KH, Wang F, Chen ST, Reynolds K, Kwatra SG, Semenov YR. Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis. J Am Acad Dermatol. 2022 03; 86(3):563-572. PMID: 33819538.
    Citations: 5     Fields:    Translation:Humans
  39. Molina GE, Zubiri L, Cohen JV, Durbin SM, Petrillo L, Allen IM, Murciano-Goroff YR, Dougan M, Thomas MF, Faje AT, Rengarajan M, Guidon AC, Chen ST, Okin D, Medoff BD, Nasrallah M, Kohler MJ, Schoenfeld SR, Karp Leaf RS, Sise ME, Neilan TG, Zlotoff DA, Farmer JR, Mooradian MJ, Bardia A, Mai M, Sullivan RJ, Semenov YR, Villani AC, Reynolds KL. Temporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018. Oncologist. 2021 06; 26(6):514-522. PMID: 33655682; PMCID: PMC8176966.
    Citations: 5     Fields:    Translation:Humans
  40. Le TK, Kaul S, Cappelli LC, Naidoo J, Semenov YR, Kwatra SG. Cutaneous adverse events of immune checkpoint inhibitor therapy: incidence and types of reactive dermatoses. J Dermatolog Treat. 2022 May; 33(3):1691-1695. PMID: 33656965; PMCID: PMC8458472.
    Citations: 2     Fields:    Translation:Humans
  41. Kalinich M, Murphy W, Wongvibulsin S, Pahalyants V, Yu KH, Lu C, Wang F, Zubiri L, Naranbhai V, Gusev A, Kwatra SG, Reynolds KL, Semenov YR. Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USA. J Immunother Cancer. 2021 03; 9(3). PMID: 33789879.
    Citations: 5     Fields:    Translation:Humans
  42. Kwatra SG, Hines H, Semenov YR, Trotter SC, Holland E, Leachman S. A Dermatologist's Guide to Implementation of Gene Expression Profiling in the Management of Melanoma. J Clin Aesthet Dermatol. 2020 Nov; 13(11 Suppl 1):s3-s14. PMID: 33349788.
    Citations: 2     
  43. Whang KA, Khanna R, Williams KA, Mahadevan V, Semenov Y, Kwatra SG. Health-Related QOL and Economic Burden of Chronic Pruritus. J Invest Dermatol. 2021 04; 141(4):754-760.e1. PMID: 32941916.
    Citations: 10     Fields:    Translation:Humans
  44. Herbosa CM, Bhat TS, Semenov YR, Rosman IS, Musiek AC. Diagnostic concordance of clinical diagnosis, tissue culture, and histopathology testing for skin and soft tissue infections: A single-center retrospective study. Int J Womens Dermatol. 2020 Dec; 6(5):395-398. PMID: 33898706; PMCID: PMC8060675.
    Citations:    
  45. Almazan E, Roh YS, Belzberg M, Qin CX, Williams K, Choi J, Sutaria N, Kaffenberger B, Semenov YR, Alhariri J, Kwatra SG. Comorbidities Associated with Granuloma Annulare: A Cross-Sectional, Case-Control Study. Medicines (Basel). 2020 Aug 28; 7(9). PMID: 32872212.
    Citations: 1     
  46. Bhat TS, Herbosa CM, Rosenberg AR, Sogade O, Jeffe DB, Mehta-Shah N, Semenov YR, Musiek AC. Current measures are not sufficient: an interview-based qualitative assessment of quality of life in cutaneous T-cell lymphoma. Br J Dermatol. 2021 02; 184(2):310-318. PMID: 32510571; PMCID: PMC7722174.
    Citations: 2     Fields:    Translation:Humans
  47. Osemwota O, Herbosa CM, Zhong C, Kwatra SG, Kim BS, Semenov YR. Ethnic variations in scalp pruritus and hair loss. J Am Acad Dermatol. 2021 Mar; 84(3):792-794. PMID: 32485212.
    Citations:    Fields:    Translation:Humans
  48. Herbosa CM, Hodges W, Mann C, Demehri S, Cornelius LA, Semenov YR. Risk of cancer in psoriasis: study of a nationally representative sample of the US population with comparison to a single-institution cohort. J Eur Acad Dermatol Venereol. 2020 Sep; 34(9):e529-e531. PMID: 32277504.
    Citations: 1     Fields:    Translation:Humans
  49. Phelan PS, Semenov YR, Nahmias ZP. Worldwide seasonal variation in search volume for cutaneous warts from 2004 to 2019. J Am Acad Dermatol. 2021 May; 84(5):1417-1419. PMID: 32387653.
    Citations:    Fields:    Translation:Humans
  50. Herbosa CM, Semenov YR, Rosenberg AR, Mehta-Shah N, Musiek AC. Clinical severity measures and quality-of-life burden in patients with mycosis fungoides and Sézary syndrome: comparison of generic and dermatology-specific instruments. J Eur Acad Dermatol Venereol. 2020 May; 34(5):995-1003. PMID: 31630443.
    Citations: 8     Fields:    Translation:Humans
  51. Kwatra SG, Boozalis E, Huang AH, Nanni C, Khanna R, Williams KA, Semenov YR, Roberts CM, Burns RF, Krischak M, Kwatra MM. Proteomic and Phosphoproteomic Analysis Reveals that Neurokinin-1 Receptor (NK1R) Blockade with Aprepitant in Human Keratinocytes Activates a Distinct Subdomain of EGFR Signaling: Implications for the Anti-Pruritic Activity of NK1R Antagonists. Medicines (Basel). 2019 Dec 09; 6(4). PMID: 31835310; PMCID: PMC6963385.
    Citations: 2     
  52. Bigelow RT, Semenov YR, Hoffman HJ, Agrawal Y. Association between vertigo, cognitive and psychiatric conditions in US children: 2012 National Health Interview Survey. Int J Pediatr Otorhinolaryngol. 2020 Mar; 130:109802. PMID: 31809971.
    Citations: 8     Fields:    Translation:Humans
  53. Huang AH, Kwatra SG, Khanna R, Semenov YR, Okoye GA, Sweren RJ. Racial Disparities in the Clinical Presentation and Prognosis of Patients with Mycosis Fungoides. J Natl Med Assoc. 2019 Dec; 111(6):633-639. PMID: 31623818.
    Citations: 5     Fields:    Translation:Humans
  54. Belzberg M, Larson VA, Khanna R, Williams KA, Semenov Y, Ständer S, Grossberg AL, Kwatra SG. Association between Itch and Cancer in 3836 Pediatric Pruritus Patients at a Tertiary Care Center. Medicines (Basel). 2019 Oct 05; 6(4). PMID: 31590346; PMCID: PMC6963483.
    Citations: 3     
  55. Semenov YR, Herbosa CM, Rogers AT, Huang A, Kwatra SG, Cohen B, Anadkat MJ, Silverberg JI. Psoriasis and mortality in the United States: Data from the National Health and Nutrition Examination Survey. J Am Acad Dermatol. 2021 08; 85(2):396-403. PMID: 31415837.
    Citations: 8     Fields:    Translation:Humans
  56. Semenov YR, Rosenberg AR, Herbosa C, Mehta-Shah N, Musiek AC. Health-related quality of life and economic implications of cutaneous T-cell lymphoma. Br J Dermatol. 2020 01; 182(1):190-196. PMID: 30920642.
    Citations: 7     Fields:    Translation:Humans
  57. Semenov YR, Hsiang EY, Huang A, Herbosa CM, Hui X, Kwatra SG, Cohen B, Anadkat MJ. Association Between Psoriasis with Arthritis and Hearing Impairment in US Adults: Data from the National Health and Nutrition Examination Survey. J Rheumatol. 2019 06; 46(6):587-594. PMID: 30647186.
    Citations:    Fields:    Translation:Humans
  58. Rosenberg AR, Weston SJ, Deshields T, Fields RC, Linette GP, Cornelius LA, Semenov YR. Health-related quality of life in patients with malignant melanoma by stage and treatment status. J Am Acad Dermatol. 2021 Aug; 85(2):486-489. PMID: 29906543.
    Citations:    Fields:    Translation:Humans
  59. Boozalis E, Tang O, Patel S, Semenov YR, Pereira MP, Stander S, Kang S, Kwatra SG. Ethnic differences and comorbidities of 909 prurigo nodularis patients. J Am Acad Dermatol. 2018 Oct; 79(4):714-719.e3. PMID: 29733939; PMCID: PMC6518410.
    Citations: 24     Fields:    Translation:Humans
  60. Hsiang EY, Semenov YR, Aguh C, Kwatra SG. Seasonality of hair loss: a time series analysis of Google Trends data 2004-2016. Br J Dermatol. 2018 04; 178(4):978-979. PMID: 29048738.
    Citations: 1     Fields:    Translation:Humans
  61. Boozalis E, Semenov YR, Kwatra SG. Food and drug administration approval process for dermatology drugs in the United States. J Dermatolog Treat. 2018 Sep; 29(6):536-538. PMID: 29304565.
    Citations: 1     Fields:    Translation:Humans
  62. Crowson MG, Semenov YR, Tucci DL, Niparko JK. Quality of Life and Cost-Effectiveness of Cochlear Implants: A Narrative Review. Audiol Neurootol. 2017; 22(4-5):236-258. PMID: 29262414.
    Citations: 15     Fields:    Translation:Humans
  63. Agrawal Y, Pineault KG, Semenov YR. Health-related quality of life and economic burden of vestibular loss in older adults. Laryngoscope Investig Otolaryngol. 2018 02; 3(1):8-15. PMID: 29492463; PMCID: PMC5824117.
    Citations: 12     
  64. Rogers AT, Semenov YR, Kwatra SG, Okoye GA. Racial disparities in the management of acne: evidence from the National Ambulatory Medical Care Survey, 2005-2014. J Dermatolog Treat. 2018 May; 29(3):287-289. PMID: 28831837.
    Citations: 2     Fields:    Translation:Humans
  65. Grandhi R, He A, Semenov YR, Kwatra SG. Seasonal variation of itch: A study using real-time data from 2004 to 2016. J Am Acad Dermatol. 2017 Mar; 76(3):563-564. PMID: 28212763.
    Citations: 3     Fields:    Translation:Humans
  66. Bigelow RT, Semenov YR, Anson E, du Lac S, Ferrucci L, Agrawal Y. Impaired Vestibular Function and Low Bone Mineral Density: Data from the Baltimore Longitudinal Study of Aging. J Assoc Res Otolaryngol. 2016 Oct; 17(5):433-40. PMID: 27447468; PMCID: PMC5023539.
    Citations: 4     Fields:    Translation:Humans
  67. Harun A, Semenov YR, Agrawal Y. Vestibular Function and Activities of Daily Living: Analysis of the 1999 to 2004 National Health and Nutrition Examination Surveys. Gerontol Geriatr Med. 2015 Jan-Dec; 1. PMID: 26753170; PMCID: PMC4706363.
    Citations: 9     
  68. Harun A, Clark J, Semenov YR, Francis HW. The Role of Obliteration in the Achievement of a Dry Mastoid Bowl. Otol Neurotol. 2015 Sep; 36(9):1510-7. PMID: 26375974; PMCID: PMC4783175.
    Citations: 3     Fields:    Translation:Humans
  69. Bigelow RT, Semenov YR, Trevino C, Ferrucci L, Resnick SM, Simonsick EM, Xue QL, Agrawal Y. Association Between Visuospatial Ability and Vestibular Function in the Baltimore Longitudinal Study of Aging. J Am Geriatr Soc. 2015 Sep; 63(9):1837-44. PMID: 26311169.
    Citations: 42     Fields:    Translation:Humans
  70. Semenov YR, Bigelow RT, Xue QL, du Lac S, Agrawal Y. Association Between Vestibular and Cognitive Function in U.S. Adults: Data From the National Health and Nutrition Examination Survey. J Gerontol A Biol Sci Med Sci. 2016 Feb; 71(2):243-50. PMID: 26219850; PMCID: PMC5864155.
    Citations: 35     Fields:    Translation:Humans
  71. Bigelow RT, Semenov YR, du Lac S, Hoffman HJ, Agrawal Y. Vestibular vertigo and comorbid cognitive and psychiatric impairment: the 2008 National Health Interview Survey. J Neurol Neurosurg Psychiatry. 2016 Apr; 87(4):367-72. PMID: 25886779.
    Citations: 28     Fields:    Translation:Humans
  72. Cohen SP, Hayek S, Semenov Y, Pasquina PF, White RL, Veizi E, Huang JH, Kurihara C, Zhao Z, Guthmiller KB, Griffith SR, Verdun AV, Giampetro DM, Vorobeychik Y. Epidural steroid injections, conservative treatment, or combination treatment for cervical radicular pain: a multicenter, randomized, comparative-effectiveness study. Anesthesiology. 2014 Nov; 121(5):1045-55. PMID: 25335172.
    Citations:    
  73. Ejaz A, Semenov E, Spolverato G, Kim Y, Tanner D, Hundt J, Pawlik TM. Synchronous primary colorectal and liver metastasis: impact of operative approach on clinical outcomes and hospital charges. HPB (Oxford). 2014 Dec; 16(12):1117-26. PMID: 24965845.
    Citations: 5     Fields:    Translation:Humans
  74. Sun DQ, Ward BK, Semenov YR, Carey JP, Della Santina CC. Bilateral Vestibular Deficiency: Quality of Life and Economic Implications. JAMA Otolaryngol Head Neck Surg. 2014 Jun; 140(6):527-34. PMID: 24763518; PMCID: PMC4208975.
    Citations: 55     Fields:    Translation:Humans
  75. Semenov YR, Yeh ST, Seshamani M, Wang NY, Tobey EA, Eisenberg LS, Quittner AL, Frick KD, Niparko JK. Age-dependent cost-utility of pediatric cochlear implantation. Ear Hear. 2013 Jul-Aug; 34(4):402-12. PMID: 23558665.
    Citations: 15     Fields:    Translation:Humans
  76. Chan JY, Semenov YR, Gourin CG. Postoperative urinary tract infection and short-term outcomes and costs in head and neck cancer surgery. Otolaryngol Head Neck Surg. 2013 Apr; 148(4):602-10. PMID: 23348871.
    Citations: 5     Fields:    Translation:Humans
  77. Hennessey P, Semenov YR, Gourin CG. The effect of deep venous thrombosis on short-term outcomes and cost of care after head and neck cancer surgery. Laryngoscope. 2012 Oct; 122(10):2199-204. PMID: 22865644.
    Citations: 9     Fields:    Translation:Humans
  78. Semenov YR, Martinez-Monedero R, Niparko JK. Cochlear implants: clinical and societal outcomes. Otolaryngol Clin North Am. 2012 Oct; 45(5):959-81. PMID: 22980678.
    Citations: 13     Fields:    Translation:Humans
  79. Semenov YR, Starmer HM, Gourin CG. The effect of pneumonia on short-term outcomes and cost of care after head and neck cancer surgery. Laryngoscope. 2012 Sep; 122(9):1994-2004. PMID: 22777881.
    Citations: 21     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Semenov's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (206)
Explore
_
Co-Authors (45)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.